Sitemap - 2023 - FarmaKology’s Substack

FarmaKology-Gaza's elderly face war, displacement and medicine shortages

FarmaKology-Scientists created new antibody to combat breast cancer

FarmaKology-New deep screening technique enables rapid discovery of high-affinity antibodies to clinically relevant drug targets

FarmaKology-Mendus receives U.S. FDA Fast Track Designation for vididencel in Acute Myeloid Leukemia

FarmaKology-Pfizer’s ELREXFIO™ Receives U.S. FDA Accelerated Approval for Relapsed or Refractory Multiple Myeloma

FarmaKology-Scientists Use AI to Discover Drugs That Kill “Zombie Cells” and Fight Age-Related Diseases

FarmaKology-Regeneron Says Supreme Court Ruling Ends Patent Dispute With Amgen

MakoRx Care Connect: Empowering Independent Pharmacies and Streamlining Patient Services

Kaiser Permanente’s Outpatient Pharmacy Director Suryakumar Atmuri Offers Leadership Insights

FarmaKology-Sandoz Biologics License Application for proposed biosimilar denosumab accepted by US FDA

#nojs-banner { position: fixed; bottom: 0; left: 0; padding: 16px 16px 16px 32px; width: 100%; box-sizing: border-box; background: red; color: white; font-family: -apple-system, "Segoe UI", Roboto, Helvetica, Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol"; font-size: 13px; line-height: 13px; } #nojs-banner a { color: inherit; text-decoration: underline; } This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts